Lynovex® (NM001) is a first-in-class orphan drug candidate for cystic fibrosis.
What Is Lynovex?
A New Potential Solution to CF lung disease symptoms in Oral Form for Exacerbations (Acute use) and Inhaled Form for Long Term Use Unique Multi-Action Therapy